ArticlePCN reports : psychiatry and clinical neurosciences2022

Lemborexant for insomnia in adults with psychiatric disorders: A 1-week, open-label study.

Taro Kishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.